Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation

Conditions:   Osteoporosis;   Osteoporosis, Postmenopausal;   Osteopenia;   Bone Loss Intervention:   Drug: Zoledronic acid Sponsor:   University of Calgary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials